Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
JAMA Network Open
|
January 24, 2025
18F-Fluorodeoxyglucose Uptake in PDGFRA-Mutant Gastrointestinal Stromal Tumors
Maria Concetta Nigro, Andrea Marchetti, Elena Rosa Fumagalli, et al.
International Journal of Molecular Sciences
|
September 23, 2022
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST
Erika Fiorino, Alessandra Merlini, Lorenzo D'Ambrosio, et al.
Frontiers in Oncology
|
September 16, 2022
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination
Alessandra Merlini, Maria Laura Centomo, Giulio Ferrero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 9, 2020
CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes
Valeria Leuci, Chiara Donini, Giovanni Grignani, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 6, 2024
TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer
Muhlis Akman, Ciro Monteleone, Gabriella Doronzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2024
GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression
Silvia Stacchiotti, Silvia Martini, Sandro Pasquali, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 23, 2023
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma
Lidia Giraudo, Giulia Cattaneo, Loretta Gammaitoni, et al.
JAMA Network Open
|
November 6, 2023
Guideline-Based Follow-Up Outcomes in Patients With Gastrointestinal Stromal Tumor With Low Risk of Recurrence: A Report From the Italian Sarcoma Group
Lorenzo D'Ambrosio, Elena Fumagalli, Tommaso Martino De Pas, et al.
Journal of Translational Medicine
|
March 11, 2026
Unraveling lung cancer dynamics: a new metabolic signature improving the prediction of recurrence in resected lung adenocarcinoma
Francesca Jacobs, Lorenzo Manganaro, Lorenzo D'Ambrosio, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 18, 2025
A prospective study on clinicians' attitudes and survival outcomes for patients with advanced NSCLC and poor performance status in the immunotherapy era: PICASO (GOIRC-04-2020)
Francesco Facchinetti, Andrea Camerini, Chiara Bennati, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
JAMA Network Open
|
January 24, 2025
18F-Fluorodeoxyglucose Uptake in PDGFRA-Mutant Gastrointestinal Stromal Tumors
Maria Concetta Nigro, Andrea Marchetti, Elena Rosa Fumagalli, et al.
International Journal of Molecular Sciences
|
September 23, 2022
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST
Erika Fiorino, Alessandra Merlini, Lorenzo D'Ambrosio, et al.
Frontiers in Oncology
|
September 16, 2022
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination
Alessandra Merlini, Maria Laura Centomo, Giulio Ferrero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 9, 2020
CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes
Valeria Leuci, Chiara Donini, Giovanni Grignani, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 6, 2024
TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer
Muhlis Akman, Ciro Monteleone, Gabriella Doronzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2024
GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression
Silvia Stacchiotti, Silvia Martini, Sandro Pasquali, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 23, 2023
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma
Lidia Giraudo, Giulia Cattaneo, Loretta Gammaitoni, et al.
JAMA Network Open
|
November 6, 2023
Guideline-Based Follow-Up Outcomes in Patients With Gastrointestinal Stromal Tumor With Low Risk of Recurrence: A Report From the Italian Sarcoma Group
Lorenzo D'Ambrosio, Elena Fumagalli, Tommaso Martino De Pas, et al.
Journal of Translational Medicine
|
March 11, 2026
Unraveling lung cancer dynamics: a new metabolic signature improving the prediction of recurrence in resected lung adenocarcinoma
Francesca Jacobs, Lorenzo Manganaro, Lorenzo D'Ambrosio, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 18, 2025
A prospective study on clinicians' attitudes and survival outcomes for patients with advanced NSCLC and poor performance status in the immunotherapy era: PICASO (GOIRC-04-2020)
Francesco Facchinetti, Andrea Camerini, Chiara Bennati, et al.
Page
of 5